Provided by Tiger Fintech (Singapore) Pte. Ltd.

Black TITAN Corp

9.25
-14.7300-61.43%
Post-market: 11.051.80+19.44%19:59 EDT
Volume:2.86M
Turnover:41.42M
Market Cap:12.30M
PE:-3.14
High:23.48
Open:17.50
Low:8.80
Close:23.98
52wk High:39.00
52wk Low:3.03
Shares:1.33M
Float Shares:723.50K
Volume Ratio:1.97
T/O Rate:395.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9464
EPS(LYR):-5.2347
ROE:--
ROA:--
PB:--
PE(LYR):-1.77

Loading ...

Company Profile

Company Name:
Black TITAN Corp
Exchange:
NASDAQ
Establishment Date:
1990
Employees:
- -
Office Location:
Lot 2-3 & 2-4, Hive 8,MRanti Park,Bukit Jalil,Kuala Lumpur,Wilayah Persekutuan,Malaysia
Zip Code:
57000
Fax:
60 3 8996 5092
Introduction:
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder. The company was founded in 1991 and is based in South San Francisco, California.

Directors

Name
Position
David Lazar
Director,Chief Executive Officer
Marc Rubin
Executive Chairman
Katherine Beebe DeVarney
President and Chief Operating Officer,Director
Avraham Ben Tzvi
Director
David Natan
Director
Eric Greenberg
Director
James R. McNab, Jr.
Director
Joseph A. Akers
Director
M. David MacFarlane
Director
Matthew C. McMurdo
Director
Peter L. Chasey
Director

Shareholders

Name
Position
David Lazar
Director,Chief Executive Officer
Katherine Beebe DeVarney
President and Chief Operating Officer,Director